Hanall Biopharma Co., Ltd. (009420.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 2.18T |
| Enterprise Value | 2.19T |
| P/E Ratio | -115.61 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 15.61 |
| Price/Book Ratio | 16.05 |
| Enterprise/Revenue | 15.7 |
| Enterprise/EBITDA | -187.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.14 |
| Operating Margin | 0.03 |
| Return On Assets | -0.09 |
| Return On Equity | -0.14 |
| Revenue | 155.18B |
| Revenue/Share | 3,096.48 |
| Gross Profit | 79.1B |
| EBITDA | 1.94B |
| Net Income | -5.56B |
| Diluted EPS | -111.55 |
| Total Cash | 30.2B |
| Total Cash/Share | 578.01 |
| Total Debt | 44.99B |
| Total Debt/Equity | 0.28 |
| Current Ratio | 1.49 |
| Book Value Per Share | 3,093.85 |
| 52-Week Change | 26.66 |
| 52-Week High | 73,000 |
| 52-Week Low | 35,100 |
| Moving Average 50 Days | 45,200 |
| Moving Average 200 Days | 51,402.75 |
| Average Volume | 263,359 |
| Shares Outstanding | 50.86M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | May 03, 2006 |